Quality of life of patients with cardiomyopathy treated with sacubitril/valsartan vs. standard therapy during or after COVID-19 in Kazakhstan


	Graphical presentation of the linear regression analysis.

Part of: Dadanbekova D, Zhakipbekov K, Kodasbayev A, Datkhayev U, Petrova G, Tachkov K (2024) Quality of life of patients with cardiomyopathy treated with sacubitril/valsartan vs. standard therapy during or after COVID-19 in Kazakhstan. Pharmacia 71: 1-6. https://doi.org/10.3897/pharmacia.71.e125055